Has Robert Timmerman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $77,382 in general payments to Robert Timmerman, MD across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Timmerman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Timmerman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Timmerman, MD

Radiation Oncology · Dallas, TXNPI 1407814353

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (59.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Elekta, Inc. at 37.0% of the total. Reporting peaked in 2023 at $24,197 and has fallen 53.0% since, to $11,371 in 2025. Among radiation oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$77,382in general payments, 2019–2025

Across 60 payments — averaging $1289.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Elekta, Inc.$29K
Boston Scientific$16K
Reflexion Medical, Inc.$10K
Elekta Limited Hong Kong$9K
Brainlab, Inc.$3K
Accuray Incorporated$3K
plus $8K from 10 others

$1,400,000in research payments, 2019–2025

Across 8 payments — averaging $175,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Elekta Limited$550K
Siemens Medical Solutions USA, Inc.$510K
Varian Medical Systems, Inc.$340K

What the payments were for

Consulting fees$14,47019%
Speaking & faculty fees$14,27918%
Travel & lodging$46,03759%
Food & beverage$2,4193%
Gifts$1780%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Elekta, Inc.	5	$28,629
Boston Scientific	12	$16,063
Reflexion Medical, Inc.	12	$9,609
Elekta Limited Hong Kong	6	$9,126
Brainlab, Inc.	2	$3,136
Accuray Incorporated	2	$2,700
IBA Proton Therapy, Inc.	2	$2,152
Elekta Pte. Ltd	1	$1,500
Elekta Instrument AB	1	$1,349
Varian Medical Systems, Inc.	1	$1,200
GE HealthCare	6	$994
Elekta AB (publ)	4	$245
Siemens Medical Solutions USA, Inc.	2	$227
United Imaging Healthcare North America, Inc.	2	$207
Telix Pharmaceuticals	1	$128
Biosense Webster, Inc.	1	$117

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ELEKTA MEDICAL LINEAR ACCELERATOR$29,333
GENERAL BPH$14,352
REFLEXION MEDICAL RADIOTHERAPY SYSTEM$9,470
Surgical planning and navigation radiation treatment planning and positioning$3,101
ELEKTA UNITY$1,636
GENERAL - THERAPIES$1,624
CyberKnife System$1,500
Icon$1,349
Perfection$1,349
ILLUCCIX$257
Varian Treatment$139
uRT$130
Carto Smarttouch$117
Carto 3 System$117

How this compares

$77,382 in reported general payments places this provider in the 95th percentile of 418 radiation oncology providers in Texas.

See all radiation oncology providers in Texas →

Medicare billing

Part B allowed, 2024

$49,065

Medicare patients

Services billed

513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Dallas

Hak ChoyDallas$119K
Puneeth IyengarDallas$60K
Assal RahimiDallas$43K
Neil DesaiDallas$29K
Kiran KumarDallas$29K
Kenneth WestoverDallas$24K
Jonathan VermaDallas$6K
James WelshHouston$421K
Stephen ChunHouston$344K
Jim HsiangCorpus Christi$258K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →